Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Operating Expenses (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Operating Expenses data on record, last reported at $2.8 million in Q4 2019.

  • For Q4 2019, Operating Expenses rose 30.78% year-over-year to $2.8 million; the TTM value through Dec 2019 reached $11.6 million, up 59.66%, while the annual FY2024 figure was $26.7 million, 25.46% up from the prior year.
  • Operating Expenses reached $2.8 million in Q4 2019 per DMAC's latest filing, up from $2.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.4 million in Q1 2019 and bottomed at $1.3 million in Q1 2018.